CCMG & Garrod 2026 Joint Conference
June 7-10, 2026
Hotel Château-Bromont
Bromont, Quebec
Breakfast Symposium – Toward the full genomic picture: real-time, multiomic profiling in rare disease and pediatric oncology with Oxford Nanopore Sequencing
This symposium is not accredited.
*Breakfast will be provided for those attending the sponsored breakfast session only.
Join us at the Breakfast Symposium on Wednesday to hear how Oxford Nanopore Technologies continues to redefine genomic sequencing through a portfolio of innovations — from long-read and ultra-long-read sequencing to methylation detection, adaptive sampling, and telomere-to-telomere assembly. This session opens with Alex Lindell, Senior Director of Product Marketing giving an overview of these advances and their collective potential to transform rare disease genomics. Building on that foundation, our second presenter, Dr. Vincent-Philippe Lavallée of the CHU Sainte-Justine and the Université de Montréal will demonstrate the clinical power of real-time Oxford Nanopore sequencing in pediatric oncology. Dr. Lavallée will share a standardized ONT Whole-Genome Sequencing approach using Adaptive Sampling (AS-WGS) that consolidates multi-step diagnostic workflows into a single, rapid assay — delivering comprehensive tumor profiling when it matters most.
Speakers:
Roger Bialy
Director, Regional Sales – Canada
Oxford Nanopore Technologies
Alex Lindell
Senior Director, Product Marketing
Oxford Nanopore Technologies
Alex Lindell is Senior Director of Product Marketing at Oxford Nanopore Technologies. Prior to this role, he was Head of Genetic Disease Product Management at Oxford Nanopore. Alex previously held roles at Illumina and Lineagen where he focused on developing solutions to major unmet medical needs including rare and undiagnosed genetic diseases, neurodegenerative diseases, pulmonary diseases, pharmacogenomics, and transplant genomics.
Dr. Vincent-Philipe Lavallée
Hematologistoncologist / Associate Professor
CHU Sainte-Justine, Université de Montréal
Bio: Vincent-Philippe Lavallée, MD PhD, is a hematologistoncologist at CHU Sainte Justine and Associate Professor at Université de Montréal. Trained in internal medicine, hematology, molecular biology, and computational biology, his work focuses on cancer genomics, particularly acute myeloid leukemia. He integrates exome, transcriptome, single cell, and longread sequencing into clinical diagnostics and contributes to provincial pediatric oncology testing. He also leads the Méta Plateforme de Génomique Intégrée, advancing precision medicine through liquid biopsy development and near real time genomic testing.
Event Timeslots (1)
Day 4
-
Bromont ABC - Speakers: Roger Bialy, Alex Lindell, Vincent-Philipe Lavallée. Not accredited. Breakfast will be provided for those attending the sponsored breakfast session only.
